Gene · 4607
NIH grants2,246
NIH grants whose papers are about the gene, through NIH's grant-paper links.
801 to 820 of 2,246
Download this page as JSON| Grant | Title | MYBPC3 papers | Newest fiscal year |
|---|---|---|---|
| R01HL139738 | KCNJ2-Induced Arrhythmia Mechanisms in CPVT and Heart Failure. | 1 | 2021 |
| R01HL139806 | Modeling thoracic aortic aneurysm in zebrafish | 1 | 2021 |
| R01HL140224 | Eicosanoid Profiles as Determinants of HFpEF | 1 | 2021 |
| R01HL141292 | A Social Epigenomic Approach to Health Disparities in Cardiovascular Risk Factors | 1 | 2021 |
| R01HL141570 | Perfusable 3D human cardiac constructs for heart regeneration | 1 | 2021 |
| R01HL141892 | Impact of Disparities Affecting Survival among Advanced Heart Failure Patients and Transplant Recipients | 1 | 2021 |
| R01HL142216 | Aberrant Circadian Regulation of Autophagy in the Heart During Diabetes | 1 | 2021 |
| R01NS036232 | Neuronal function of huntingtin-associated protein | 1 | 2021 |
| R01NS081366 | GAA REPEATS INDUCED EPIGENETIC SILENCING IN FRIEDREICH'S ATAXIA | 1 | 2021 |
| R01NS094692 | Targeting TFEB To Microglia and Monocytes to Enhance Amyloid Degradation | 1 | 2021 |
| R01NS101701 | N-terminal huntingtin and Huntington disease neuropathology | 1 | 2021 |
| R21AI148877 | Role of ontogeny and niche on human macrophage development | 1 | 2021 |
| R21AI152318 | Adipose-derived biogenic nanoparticles for treatment of myocarditis/DCM(MPDPI) | 1 | 2021 |
| R21AI154927 | Sex differences in exercise-induced mitochondrial function during viral myocarditis | 1 | 2021 |
| R25GM061838 | NIGMS RISE Program at the UPR Medical Sciences Campus | 1 | 2021 |
| R37AG028730 | SIRT1 as a regulator of health and lifespan of mammals | 1 | 2021 |
| R43HG010852 | Administrative Supplement: Functional Assessment of Variants in Organisms of Research (FAVOR) - Profiling Canonical Human Genes and their Variants through Disease Model Phenotyping. | 1 | 2021 |
| RF1AG068992 | Cell autonomous and non-cell autonomous phenotypes due to genetic risk for late onset Alzheimers disease | 1 | 2021 |
| RF1AG074010 | Dissect the interplay between sex and APOE at the single cell level to uncover novel pathways, targets and therapeutics for Alzheimer's disease | 1 | 2021 |
| RF1MH123163 | Redefine Trans-Neuropsychiatric Disorder Brain Patterns through Big-Data and Machine Learning | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/grants?page=41